These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8588031)

  • 1. [Detection of liver tumors].
    Rummeny EJ; Reimer P; Daldrup H; Peters PE
    Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
    Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
    Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP.
    Ba-Ssalamah A; Heinz-Peer G; Schima W; Schibany N; Schick S; Prokesch RW; Kaider A; Teleky B; Wrba F; Lechner G
    J Magn Reson Imaging; 2000 Jun; 11(6):665-72. PubMed ID: 10862066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
    Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
    MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
    van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
    Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
    Pleger B; Beyer HK; Laufer U
    Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
    Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
    J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.
    Kondo H; Kanematsu M; Hoshi H; Murakami T; Kim T; Hori M; Matsuo M; Nakamura H
    AJR Am J Roentgenol; 2000 Apr; 174(4):947-54. PubMed ID: 10749228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
    Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
    Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
    Oudkerk M; van den Heuvel AG; Wielopolski PA; Schmitz PI; Borel Rinkes IH; Wiggers T
    Radiology; 1997 May; 203(2):449-56. PubMed ID: 9114103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
    Soyer P
    Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.